Filing Details

Accession Number:
0001352413-18-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-13 16:16:46
Reporting Period:
2018-07-11
Accepted Time:
2018-07-13 16:16:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352413 Christopher Mark Capone 320 Wakara Way
Salt Lake City UT 84108
President & C.e.o. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-11 77,654 $30.12 409,829 No 4 M Direct
Common Stock Disposition 2018-07-11 77,654 $41.00 332,175 No 4 S Direct
Common Stock Acquisiton 2018-07-11 2,346 $30.12 334,521 No 4 M Direct
Common Stock Disposition 2018-07-11 2,346 $41.00 332,175 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2018-07-11 2,346 $0.00 2,346 $30.12
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-07-11 77,654 $0.00 77,654 $30.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-18 2019-02-18 No 4 M Direct
0 2013-02-18 2019-02-18 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.